SLC29A1 and cholangiocarcinoma: Nevertheless, existing research investigating the prognostic and predictive significance of hENT1 in cholangiocarcinoma has faced limitations in the form of small sample sizes and the absence of a dependable antibody for precise determination of hENT1 levels by techniques such as Western blot as well as immunohistochemistry.